TTOO Historical Balance Sheet

TTOO Stock

USD 5.63 0.18 3.30%

Trend analysis of T2 Biosystms balance sheet accounts such as Other Liabilities of 5.9 M, Property Plant And Equipment Net of 9.8 M, Net Debt of 35.5 M or Accounts Payable of 1.6 M provides information on T2 Biosystms' total assets, liabilities, and equity, which is the actual value of T2 Biosystms to its prevalent stockholders. By breaking down trends over time using T2 Biosystms balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining T2 Biosystms latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether T2 Biosystms is a good buy for the upcoming year.

T2 Biosystms Inventory

2.85 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

About TTOO Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of T2 Biosystms at a specified time, usually calculated after every quarter, six months, or one year. T2 Biosystms Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of T2 Biosystms and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which TTOO currently owns. An asset can also be divided into two categories, current and non-current.

T2 Biosystms Balance Sheet Chart

T2 Biosystms Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how T2 Biosystms uses and utilizes its capital. It also shows what exactly a company owns and owes.

At this time, T2 Biosystms' Cash is very stable compared to the past year. As of the 22nd of May 2024, Non Current Assets Total is likely to grow to about 11.6 M, while Short and Long Term Debt Total is likely to drop about 42 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of T2 Biosystms assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in T2 Biosystms books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on T2 Biosystms balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of T2 Biosystms are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from T2 Biosystms' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into T2 Biosystms current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.At this time, T2 Biosystms' Cash is very stable compared to the past year. As of the 22nd of May 2024, Non Current Assets Total is likely to grow to about 11.6 M, while Short and Long Term Debt Total is likely to drop about 42 M.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	57.1M	59.2M	49.5M	42.0M
Total Assets	60.5M	34.4M	34.8M	43.7M

Short Long Term Debt Total Total Assets

T2 Biosystms balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Total Assets		0.49	0.19	0.0	0.92	0.06	0.6	-0.33	-0.13	0.08	0.81	0.59	0.46	0.26	0.38	0.92	0.15	-0.09	0.34	-0.35	0.28	0.33	-0.56	0.31	0.97	-0.06
Short Long Term Debt Total	0.49		0.81	0.49	0.44	0.61	0.93	0.61	-0.87	0.58	0.04	0.87	-0.24	0.38	0.84	0.16	0.79	0.23	0.4	-0.5	0.86	0.96	-0.3	0.78	0.31	0.38
Other Current Liab	0.19	0.81		0.82	0.25	0.35	0.62	0.57	-0.79	0.68	-0.07	0.51	-0.31	0.01	0.73	-0.05	0.6	0.36	0.07	-0.72	0.67	0.84	-0.28	0.66	0.08	0.74
Total Current Liabilities	0.0	0.49	0.82		0.1	0.2	0.29	0.41	-0.6	0.37	-0.04	0.17	-0.33	-0.43	0.37	-0.09	0.4	0.61	-0.2	-0.81	0.32	0.54	-0.29	0.58	-0.03	0.99
Total Stockholder Equity	0.92	0.44	0.25	0.1		-0.06	0.5	-0.37	-0.09	0.02	0.82	0.45	0.43	0.21	0.35	0.88	0.07	-0.04	0.17	-0.58	0.23	0.29	-0.83	0.27	0.92	0.04
Other Liab	0.06	0.61	0.35	0.2	-0.06		0.56	0.71	-0.83	0.32	-0.33	0.61	-0.6	0.18	0.57	-0.21	0.95	0.61	0.42	-0.03	0.81	0.7	0.09	0.81	-0.09	0.14
Property Plant And Equipment Net	0.6	0.93	0.62	0.29	0.5	0.56		0.48	-0.73	0.54	0.15	0.94	-0.03	0.4	0.74	0.29	0.69	0.12	0.47	-0.35	0.73	0.84	-0.27	0.74	0.43	0.17
Net Debt	-0.33	0.61	0.57	0.41	-0.37	0.71	0.48		-0.81	0.59	-0.75	0.52	-0.58	0.14	0.53	-0.65	0.79	0.34	0.38	-0.09	0.69	0.7	0.26	0.58	-0.51	0.35
Retained Earnings	-0.13	-0.87	-0.79	-0.6	-0.09	-0.83	-0.73	-0.81		-0.57	0.27	-0.68	0.61	-0.17	-0.8	0.18	-0.95	-0.57	-0.28	0.43	-0.89	-0.94	0.1	-0.88	0.03	-0.52
Accounts Payable	0.08	0.58	0.68	0.37	0.02	0.32	0.54	0.59	-0.57		-0.28	0.51	-0.17	0.21	0.61	-0.18	0.5	0.03	0.37	-0.22	0.59	0.57	0.04	0.42	-0.05	0.26
Cash	0.81	0.04	-0.07	-0.04	0.82	-0.33	0.15	-0.75	0.27	-0.28		0.04	0.46	0.04	0.0	0.96	-0.29	-0.09	-0.2	-0.34	-0.19	-0.11	-0.61	-0.01	0.92	-0.05
Non Current Assets Total	0.59	0.87	0.51	0.17	0.45	0.61	0.94	0.52	-0.68	0.51	0.04		0.08	0.36	0.68	0.25	0.7	0.06	0.72	-0.21	0.73	0.78	-0.18	0.67	0.39	0.06
Non Currrent Assets Other	0.46	-0.24	-0.31	-0.33	0.43	-0.6	-0.03	-0.58	0.61	-0.17	0.46	0.08		-0.09	-0.33	0.54	-0.6	-0.61	0.29	0.07	-0.47	-0.39	-0.18	-0.46	0.48	-0.32
Other Assets	0.26	0.38	0.01	-0.43	0.21	0.18	0.4	0.14	-0.17	0.21	0.04	0.36	-0.09		0.28	0.11	0.21	-0.52	0.26	0.25	0.4	0.28	-0.01	-0.06	0.19	-0.51
Long Term Debt	0.38	0.84	0.73	0.37	0.35	0.57	0.74	0.53	-0.8	0.61	0.0	0.68	-0.33	0.28		0.09	0.73	0.27	0.32	-0.39	0.86	0.88	-0.23	0.69	0.24	0.27
Cash And Short Term Investments	0.92	0.16	-0.05	-0.09	0.88	-0.21	0.29	-0.65	0.18	-0.18	0.96	0.25	0.54	0.11	0.09		-0.16	-0.13	0.07	-0.3	-0.05	-0.01	-0.59	0.07	0.98	-0.11
Common Stock Total Equity	0.15	0.79	0.6	0.4	0.07	0.95	0.69	0.79	-0.95	0.5	-0.29	0.7	-0.6	0.21	0.73	-0.16		0.59	0.43	-0.27	0.91	0.86	-0.06	0.88	-0.01	0.32
Common Stock Shares Outstanding	-0.09	0.23	0.36	0.61	-0.04	0.61	0.12	0.34	-0.57	0.03	-0.09	0.06	-0.61	-0.52	0.27	-0.13	0.59		-0.19	-0.46	0.35	0.37	-0.2	0.75	-0.1	0.62
Short Term Investments	0.34	0.4	0.07	-0.2	0.17	0.42	0.47	0.38	-0.28	0.37	-0.2	0.72	0.29	0.26	0.32	0.07	0.43	-0.19		0.2	0.49	0.35	0.13	0.22	0.18	-0.26
Non Current Liabilities Total	-0.35	-0.5	-0.72	-0.81	-0.58	-0.03	-0.35	-0.09	0.43	-0.22	-0.34	-0.21	0.07	0.25	-0.39	-0.3	-0.27	-0.46	0.2		-0.28	-0.47	0.78	-0.5	-0.35	-0.79
Other Current Assets	0.28	0.86	0.67	0.32	0.23	0.81	0.73	0.69	-0.89	0.59	-0.19	0.73	-0.47	0.4	0.86	-0.05	0.91	0.35	0.49	-0.28		0.92	-0.12	0.75	0.12	0.22
Other Stockholder Equity	0.33	0.96	0.84	0.54	0.29	0.7	0.84	0.7	-0.94	0.57	-0.11	0.78	-0.39	0.28	0.88	-0.01	0.86	0.37	0.35	-0.47	0.92		-0.19	0.82	0.16	0.44
Total Liab	-0.56	-0.3	-0.28	-0.29	-0.83	0.09	-0.27	0.26	0.1	0.04	-0.61	-0.18	-0.18	-0.01	-0.23	-0.59	-0.06	-0.2	0.13	0.78	-0.12	-0.19		-0.27	-0.6	-0.26
Property Plant And Equipment Gross	0.31	0.78	0.66	0.58	0.27	0.81	0.74	0.58	-0.88	0.42	-0.01	0.67	-0.46	-0.06	0.69	0.07	0.88	0.75	0.22	-0.5	0.75	0.82	-0.27		0.18	0.5
Total Current Assets	0.97	0.31	0.08	-0.03	0.92	-0.09	0.43	-0.51	0.03	-0.05	0.92	0.39	0.48	0.19	0.24	0.98	-0.01	-0.1	0.18	-0.35	0.12	0.16	-0.6	0.18		-0.07
Short Term Debt	-0.06	0.38	0.74	0.99	0.04	0.14	0.17	0.35	-0.52	0.26	-0.05	0.06	-0.32	-0.51	0.27	-0.11	0.32	0.62	-0.26	-0.79	0.22	0.44	-0.26	0.5	-0.07

Click cells to compare fundamentals

T2 Biosystms Account Relationship Matchups

T2 Biosystms balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	28.5M	79.1M	60.5M	34.4M	34.8M	43.7M
Short Long Term Debt Total	44.8M	55.8M	57.1M	59.2M	49.5M	42.0M
Other Current Liab	13.6M	6.4M	7.2M	7.7M	11.5M	7.1M
Total Current Liabilities	60.6M	9.8M	11.7M	10.5M	56.2M	59.0M
Total Stockholder Equity	(34.0M)	8.7M	(12.9M)	(40.0M)	(28.0M)	(26.6M)
Other Liab	46K	4.8M	4.6M	4.9M	5.6M	5.9M
Property Plant And Equipment Net	9.2M	14.8M	14.4M	13.3M	9.1M	9.8M
Net Debt	33.7M	39.0M	34.9M	48.9M	33.8M	35.5M
Retained Earnings	(376.2M)	(423.0M)	(472.2M)	(534.5M)	(584.3M)	(555.1M)
Accounts Payable	3.8M	2.1M	2.8M	1.3M	1.5M	1.6M
Cash	11.0M	16.8M	22.2M	10.3M	15.7M	28.6M
Non Current Assets Total	9.6M	25.5M	16.1M	15.0M	9.7M	11.6M
Cash And Short Term Investments	11.0M	42.2M	32.2M	10.3M	15.7M	31.0M
Common Stock Total Equity	36K	44K	51K	147K	169.1K	177.5K
Common Stock Shares Outstanding	9.1K	24.3K	31.8K	51.0K	2.6M	2.7M
Liabilities And Stockholders Equity	28.5M	79.1M	60.5M	34.4M	34.8M	43.7M
Non Current Liabilities Total	1.9M	60.6M	61.8M	63.9M	6.7M	6.3M
Other Current Assets	1.4M	2.7M	3.1M	2.6M	3.2M	1.7M
Other Stockholder Equity	342.1M	431.5M	459.2M	494.6M	556.3M	315.0M
Total Liab	62.5M	70.4M	73.4M	74.4M	62.8M	50.8M
Property Plant And Equipment Gross	9.2M	14.8M	14.4M	13.3M	23.9M	25.1M
Total Current Assets	18.9M	53.6M	44.4M	19.4M	25.1M	35.3M
Short Term Debt	42.9M	1.2M	1.2M	1.4M	42.9M	45.0M
Common Stock	49K	147K	166K	8K	4K	3.8K
Property Plant Equipment	5.8M	14.8M	14.4M	13.3M	15.3M	9.5M
Net Tangible Assets	(32.1M)	8.7M	(12.9M)	(40.0M)	(36.0M)	(34.2M)
Current Deferred Revenue	285K	230K	518K	172K	224K	212.8K
Net Receivables	2.8M	5.1M	5.1M	2.2M	1.4M	2.2M
Retained Earnings Total Equity	(266.1M)	(317.2M)	(376.2M)	(423.0M)	(380.7M)	(399.7M)
Capital Surpluse	267.4M	328.5M	342.1M	431.5M	496.3M	308.8M
Inventory	3.6M	3.6M	3.9M	4.3M	4.8M	2.9M
Short Long Term Debt	40.7M	42.4M	42.9M	41.3M	47.5M	27.2M
Capital Lease Obligations	3.9M	10.5M	9.4M	9.6M	8.2M	6.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock:

How To Invest In TTOO

Details

Is TTOO Stock a good investment?

Details

What is T2 Biosystms' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for TTOO Stock analysis

When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.

	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals

Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

109.92

Revenue Per Share

1.864

Quarterly Revenue Growth

(0.01)

Return On Assets

(1.00)

Return On Equity

(6.22)

The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TTOO Historical Balance Sheet

T2 Biosystms Inventory

2.85 Million

About TTOO Balance Sheet Analysis

T2 Biosystms Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

T2 Biosystms balance sheet Correlations

T2 Biosystms Account Relationship Matchups

High Positive Relationship

High Negative Relationship

T2 Biosystms balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for TTOO Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Term Debt	+ 0.99	Total Current Liabilities
Total Current Assets	+ 0.98	Cash And Short Term Investments
Total Current Assets	+ 0.97	Total Assets
Other Stockholder Equity	+ 0.96	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.96	Cash
Common Stock Total Equity	+ 0.95	Other Liab

Common Stock Total Equity	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.94	Retained Earnings
Other Current Assets	- 0.89	Retained Earnings
Property Plant And Equipment Gross	- 0.88	Retained Earnings
Retained Earnings	- 0.87	Short Long Term Debt Total
Retained Earnings	- 0.83	Other Liab